ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript February 28, 2023
Operator: Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I’ll be your operator for today’s call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. I will now turn the call over to Amanda Loshbaugh, Investor Relations Manager. Amanda, you may begin.
Amanda Hamilton: Thank you,...
